Korean red ginseng can be used as a possible anticancer treatment for patients with colorectal cancer. - GreenMedInfo Summary
Korean Red Ginseng Extract Increases Apoptosis by Activation of the Noxa Pathway in Colorectal Cancer.
Nutrients. 2019 Aug 29 ;11(9). Epub 2019 Aug 29. PMID: 31470581
Yoon A Jeong
BACKGROUND: Although the anticancer activity of Korean Red Ginseng (KRG) has been known in various cancers, the mechanism of KRG-induced apoptosis is unknown in colorectal cancer (CRC). In our study, we examined whether KRG induces apoptosis in CRC cells.
METHODS: In the cell viability assay, the concentration of the appropriate KRG extracts was fixed at 2.5 mg/mL in numerous CRC cells. This fixed concentration was in other experiments, and it was confirmed that the KRG extracts induce apoptosis in CRC cells.
RESULTS: We found that KRG induced Noxa activation and apoptosis and increased endoplasmic reticulum stress via reactive oxygen species production. This indicated that KRG efficiently enhanced cell death in CRC cells.
CONCLUSION: Our results show that KRG can be used as a possible anticancer drug for patients with CRC.